Investors / Altium Capital
Altium Capital
Venture capital
Altium Capital Management is an investment firm focused on long-term investments in healthcare companies, providing growth capital to private and public companies developing novel technologies for human health. Its investment universe is mostly concentrated in therapeutics within private ventures and small-cap and micro-cap public companies.
Invests inHealthcare & Biotech
In its own wordshealthcaretherapeuticsbiotechlife sciencesgrowth capitalpublic markets
Your fit with Altium Capital
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsAltium Capital lists 12 checked portfolio companies on its own site. Its largest theme is Healthcare & Biotech (100%). 86% of its companies are based in United States. It invests most often alongside 15th Rock, 4Catalyzer and Aisling Capital.
No funding round on record names Altium Capital yet, so the figures come from its portfolio page.
Round figures show recent activity, not Altium Capital's whole history. Rounds on record name 0 companies; its own site lists 12. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 30th | 12 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 100th | 100% in its largest sector |
| Reach | 42th | 2 countries |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers1192%
- No longer answers00%
- Points to another company18%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Co-investor network
who it backs companies with, and who they back togetherCompare Altium Capital head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Portfolio
12 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Antios Therapeutics develops innovative therapies to treat and cure hepatitis B virus and other viral diseases. | Healthcare & Biotech | Portfolio page | ||
| Chemomab Therapeutics is a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need | Healthcare & Biotech | Portfolio page | ||
| eGenesis develops human-compatible organs for patients with organ failure using genome engineering and transplantation | Healthcare & Biotech | Portfolio page | ||
| Hummingbird Bioscience is developing a pipeline of next-generation antibody-based therapeutics, including ADCs, for patients who do not respond to current treatments. | Healthcare & Biotech | Portfolio page | ||
| Hyperfine develops and provides a portable MRI system for brain imaging | Healthcare & Biotech | Portfolio page | ||
| Immunovant, Inc. is applying a patient-focused approach to help advance treatments for people with autoimmune diseases. | Healthcare & Biotech | Portfolio page | ||
Healthcare & Biotech | Portfolio page | |||
| Palisade Bio is a clinical-stage biopharmaceutical company developing differentiated oral therapeutics for immune-mediated and fibrotic diseases. | Healthcare & Biotech | Portfolio page | ||
| Quoin Pharmaceuticals is developing therapeutic products to address a range of rare diseases | Healthcare & Biotech | Portfolio page | ||
| Sagimet Biosciences is a clinical-stage biopharmaceutical company advancing a portfolio of novel fatty acid synthase (FASN) inhibitors. | Healthcare & Biotech | Portfolio page | ||
| Seelos Therapeutics is a company focused on developing products that address significant unmet needs in CNS disorders and in rare diseases | Healthcare & Biotech | Portfolio page | ||
| The company does not provide information on what it does on its homepage. | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- altiumcap.com
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Companies checked
- 12
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Altium Capital's profile as data
Pull Altium Capital's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/altiumcap.com
# also
GET /v1/firms/altiumcap.com/portfolio
GET /v1/firms/altiumcap.com/coinvestors
GET /v1/firms/altiumcap.com/news